GLSynthesis Inc.

GLSynthesis Inc. is a drug discovery company focusing on anti-infective and antithrombotic drugs.

  • Stage $5M in TTM Revenue
  • Industry Biotechnology
  • Location Worcester, MA, USA
  • Currency USD
  • Founded June 1996
  • Employees 16
  • Incorporation Type C-corp
  • Website glsynthesis.com

Company Summary

GLSynthesis Inc. has established a drug discovery service business (custom organic synthesis, analytical chemistry and rodent pharmacology) to provide compounds and services to pharmaceutical and biotechnology companies and research institutions, and to carry out drug and chemical product R&D through corporate contracts and small business grants.

Team

  • Ivan Borrisov Yanachkov
    CSO

    M.S. (1980) and Ph.D. (1987), University of Chemical Technology and Metallurgy, Sofia, Bulgaria. Ph.D. in Chemistry (1996), Clark University, Worcester, MA. Senior Scientist, Drug Innovation and Design, Waltham, MA. Senior Scientist, GLSynthesis, Worcester, MA. Accomplished nucleoside/tide chemist and analyst. Director of Quality Control at GLSynthesis Inc. He leads antithrombotic drug synthesis and development.

  • George Edward Wright
    CEO

    B.S in pharmacy, 1963; Ph.D. in pharmaceutical chemistry, 1967. Professor of Pharmacology, University of Massachusetts Medical School, 1974-96.

  • George Wright

Advisors

  • Jeff Donaldson, Mirick O'Connell
    Lawyer
    Unconfirmed
    Chuck Swartz, Swartz Polachek & Co.
    Accountant
    Unconfirmed

Previous Investors

  • none
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free